Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist: Receptor Selectivity and in Vitro Antihistaminic Activity

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustin   Orjales Aurelio  

Drugs in R&D, Vol. 6, Iss. 6, 2005-01 ,pp. : 371-384

Adis International

Access to resources Recommend Favorite

Molecular Determinants of Selective Agonist and Antagonist Binding to the Histamine H4 Receptor

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 661-679

Bentham Science Publishers

Access to resources Recommend Favorite

High quality of ulcer healing in rats by lafutidine, a new-type histamine H 2 -receptor antagonist: involvement of capsaicin-sensitive sensory neurons

By Ajioka Hirofusa   Matsuura Naosuke   Miyake Hidekazu  

Inflammopharmacology, Vol. 10, Iss. 4-6, 2002-12 ,pp. : 483-493

VSP

Access to resources Recommend Favorite

In Vivo Pharmacological Characterisation of Bilastine, a Potent and Selective Histamine H 1 Receptor Antagonist

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustín   Orjales Aurelio  

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

EMD 281014, a new selective serotonin 5-HT 2A receptor antagonist

By Bartoszyk G.D.   van Amsterdam C.   Bottcher H.   Seyfried C.A.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 229-230

Elsevier

Access to resources Recommend Favorite